National Community Anti-drug Coalition Institute

0
115

Funding Opportunity ID: 328835
Opportunity Number: DFCNCI-2020
Opportunity Title: National Community Anti-drug Coalition Institute
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 95.003
Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility:
Agency Code: ONDCP
Agency Name: Office of National Drug Control Policy
Posted Date: Aug 27, 2020
Close Date: Sep 25, 2020
Last Updated Date: Aug 27, 2020
Award Ceiling: $2,500,000
Award Floor: $2,500,000
Estimated Total Program Funding:
Expected Number of Awards: 1
Description: Office of National Drug Control Policy Executive Office of the President 1800 G Street, NW Washington, DC 20503 FY 2020 Notice of Funding Opportunity (NOFO) Drug-Free Communities Support Program – National Community Anti-Drug Coalition Institute (NCI) Funding Opportunity Announcement (FOA) Number: DFCNCI-2020 Catalog of Federal Domestic Assistance (CFDA) No: 95.003 Release Date: August 27, 2020 The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from any national non-profit organization that represents, provides technical assistance and training to, and has special expertise and broad, national-level experience in community anti-drug coalitions under section 1032 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1532). Deadline Applicants must register with Grants.gov prior to submitting an application. All applications are due to be submitted and in receipt of a successful validation message in Grants.gov by 5:00 p.m., Eastern Time, on September 25, 2020. Eligibility ONDCP encourages applications from national nonprofit institution/organization. Applicants must have special expertise and broad, national-level experience in community anti-drug coalitions under section 1032 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1532). HOW TO APPLY Applicants must register in, and submit applications through Grants.gov, a “one-stop storefront” to find Federal funding opportunities and apply for funding. Find complete instructions on how to register and submit an application at www.Grants.gov. Applicants that experience technical difficulties during this process should call Grants.gov Customer Support Hotline at 800-518-4726 or 606-545-5035, 24 hours a day, 7 days a week, except Federal holidays. Registering with Grants.gov is a one-time process; however, processing delays may occur, and it can take several weeks for first-time registrants to receive confirmation and a user password. ONDCP encourages applicants to register several weeks before the application submission deadline. In addition, ONDCP urges applicants to submit applications 72 hours prior to the application due date to allow time to receive validation messages or rejection notifications from Grants.gov and to correct, in a timely fashion, any problems that may have caused a rejection notification. Further, ONDCP strongly encourages all prospective applicants to sign up for Grants.gov email notifications regarding this announcement. If this announcement is cancelled or modified, individuals who sign up with Grants.gov for updates will be automatically notified. Contact Information For technical assistance with submitting an application, contact Grants.gov Customer Support Hotline at 800-518-4726 or 606-545-5035, or via email to support@grants.gov. The Grants.gov Support Hotline hours of operation are 24 hours a day, 7 days a week, except Federal holidays. For assistance with any other requirements of this solicitation, applicants may contact Helen Hernandez, Office of National Drug Control Policy, by email at DFC@ONDCP.EOP.GOV or by phone at 202-395-6665.
Version: 1





Visit the Official Webpage For More Details on National Community Anti-drug Coalition Institute

LEAVE A REPLY

Please enter your comment!
Please enter your name here